The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19
Condition:   2019 Novel Coronavirus Interventions:   Drug: HCQ01;   Other: standard of care (SOC) for COVID-19 Sponsors:   Ministry of Health Jordan;   King Hussein Cancer Center;   ACDIMA Biocenter;   Amman Pharmaceutical Industries;   Sana Pharmaceutical Industry Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2021 Category: Research Source Type: clinical trials